Haute Autorite de la Sante (HAS) suggested rolling out the campaign
in stages and on a voluntary basis, like in many other countries.
President Emmanuel Macron said last week that vaccines could start
to be administered as soon as the end of the year in France, if
approved by regulators, after hopes were raised of a quick roll-out
following promising results from trials of several candidates.
After those in nursing homes, amounting to around 840,000 people in
France, a second phase would target those aged 65 and over, as well
as some health workers, the HAS said.
Three other stages would follow, aimed at people with underlying
conditions such as diabetes, other exposed professionals and then
adults with no known other conditions.
"These recommendations will evolve other time as we get more data.
We call for vaccination on a voluntary basis," the head of HAS
Dominique Le Guludec told reporters.
[to top of second column] |
The French government is due to detail in the coming days how it
will handle its vaccines campaign.
The European Union has so far secured deals with Sanofi and
GlaxoSmithKline, Johnson & Johnson, AstraZeneca, CureVac, Pfizer and
BioNTech as well as Moderna.
With 1.9 billion doses expected at this stage to reach the EU,
France aims to secure about 295 million doses.
(Reporting by Matthias Blamont; Editing by Mattieu Protard and
Alison Williams)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|